NIVOLUMAB vs TORIPALIMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
NIVOLUMAB vs TORIPALIMAB: Safety Overview
| Metric | NIVOLUMAB | TORIPALIMAB |
|---|---|---|
| Total FAERS Reports | 87,742 | 1,344 |
| Deaths Reported | 23,086 | 65 |
| Death Rate | 26.3% | 4.8% |
| Hospitalizations | 36,530 | 823 |
| Average Patient Age | 64.2 yrs | 58.0 yrs |
| % Female Patients | 34.0% | 24.9% |
| Manufacturer | E.R. Squibb & Sons, L.L.C. | Coherus Oncology, Inc. |
| Route | INTRAVENOUS | INTRAVENOUS |
| Marketing Status | Prescription | N/A |